side effect tirzepatide Explained: The Future of Weight Management Tirzepatide Side Effects Cancer: Evidence

SURPASS-4 confirmed no significant increase in risk of cardiovascular disease with tirzepatide in a high-risk population, and a pre-specified meta-analysis demonstrated a hazard ratio of 0.8 for major adverse cardiovascular events (cardiovascular death, non-fatal stroke or myocardial infarction, or hospitalisation for unstable angina) over 55 weeks

Steroids, diphenhydramine and bronchodilators can help resolve the anaphylactoid reactions and should be given so that NAC therapy can be continued under close monitoring

It helps delay fatigue, allowing longer, more intense sessions without feeling drained

It is essential to ensure the treatment is done in a sterile, clinical environment with proper professional oversight